← back to search

Ana-Belén Blázquez

Bristol-Myers Squibb (United States) · ES
Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, Immunotherapy and Immune Responses, and Malaria Research and Control.
h-index
35
citations
4,221
works
140
NIH funding
primary concept
Biology
email

Recent publications

Lipid-targeting antiviral strategies: Current state and future perspectives.
2025cited by 9position: contributordoi
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity.
2025cited by 6position: contributordoi
Biosensors for the detection of flaviviruses: A review.
2025cited by 3position: contributordoi
Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus.
2025cited by 2position: contributordoi
Fluorescence-based biosensors for West Nile virus detection.
2025cited by 0position: contributordoi
A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial Virus.
2025cited by 0position: contributordoi
Reprogramming of liver metabolism during West Nile virus infection unveils novel aspects of disease pathophysiology.
2025cited by 0position: contributordoi
Effect of long-term moderate red wine consumption in CD1 female mice.
2025cited by 0position: contributordoi
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity
2024cited by 1position: contributordoi
Lipid signatures of West Nile virus infection unveil alterations of sphingolipid metabolism providing novel biomarkers.
2023cited by 11position: contributordoi
Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection.
2023cited by 9position: contributordoi
Identification of West Nile virus RNA-dependent RNA polymerase non-nucleoside inhibitors by real-time high throughput fluorescence screening.
2023cited by 8position: contributordoi
Mechanisms of Infection in Zika Virus.
2023cited by 0position: contributordoi
Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation.
2022cited by 4position: contributordoi
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara.
2022cited by 2position: contributordoi
Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation.
2021cited by 35position: contributordoi
Relevance of oxidative stress in inhibition of eIF2 alpha phosphorylation and stress granules formation during Usutu virus infection.
2021cited by 16position: contributordoi
Previous Usutu Virus Exposure Partially Protects Magpies (<i>Pica pica</i>) against West Nile Virus Disease But Does Not Prevent Horizontal Transmission.
2021cited by 15position: contributordoi
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Cell 2020cited by 527position: middledoi
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
Nature Cancer 2020cited by 121position: middledoi
Potential for Protein Kinase Pharmacological Regulation in <i>Flaviviridae</i> Infections.
2020cited by 12position: contributordoi
Genome Sequence of Oenococcus oeni OE37, an Autochthonous Strain Isolated from an Italian White Wine.
2020cited by 1position: contributordoi
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Cancer Immunology Research 2019cited by 71position: middledoi
Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.
2019cited by 39position: contributordoi
Current Progress of Avian Vaccines Against West Nile Virus.
2019cited by 15position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Miguel A. Martín-Acebes · INIA6 papers (2019–2025) · 6 papers (2019–2025)Juan-Carlos Saiz · Instituto Nacional de Investigacion y Tecnologia Agraria (INIA)4 papers (2019–2025)Josefina Casas · Lund University4 papers (2019–2025) · 2 papers (2023–2025)José Luis Llácer · Instituto Biomédico de Valencia2 papers (2024–2025)Julia Revuelta · Instituto de Química Orgánica General2 papers (2024–2025)Alfonso Gutiérrez-Adán · Universidad de Oviedo2 papers (2024–2025)Jordi Llop · CIC biomaGUNE2 papers (2024–2025)Maria Luisa López-Redondo · Instituto de Biomedicina de Valencia2 papers (2024–2025)Estela Escribano-Romero · MDPI2 papers (2019–2025)Ron Geller · Stanford University2 papers (2024–2025)Ana Vázquez · Instituto de Salud Carlos III2 papers (2023–2025)Alicia Forcada-Nadal · Instituto de Biomedicina de Valencia2 papers (2024–2025)Patricia Mingo · Universidad de Alcalá2 papers (2023–2025)Javier Sánchez-Céspedes · Ekaterinburg Research Institute of Viral Infections2 papers (2023–2025)Nereida Jiménez de Oya · MDPI2 papers (2019–2025)José Miguel Cisneros · Sociedad Española de Cardiología2 papers (2023–2025)Patrick A. Ott · Harvard University1 papers (2019–2019)Michael Lattanzi · New York University1 papers (2019–2019)